Skip to main content
 

Diversity by Design

Seres Therapeutics has built a proprietary discovery and design platform that enables us to understand the dysbiosis associated with specific diseases.

More

Product Pipeline

We are developing a novel class of biological drugs designed to treat disease by restoring the function of a dysbiotic mircobiome.

More

Clinical Trials

We have multiple active clinical studies to evaluate our microbiome therapy clinical candidates.

More

Back to top